PHR1101 Bridge to practice 2
Faculty of Pharmacy and Pharmaceutical Sciences
PHR1101 Bridge to practice 2 is a 6-credit-point, undergraduate unit from the Faculty of Pharmacy and Pharmaceutical Sciences, offered in 2025 in Semester 1 at Parkville. It needs PHR1001.
- Credit points
- 6
- Offered in 2025
- Semester 1
- Parkville
- Assessment
- Exam 70%
- and 2 other tasks
This is the 2025 handbook entry. See the 2027 entry.
Reviews
No reviews yetNo reviews yet. Be the first to review PHR1101.
Requisites
Before PHR1101
Prerequisites
Pass these before you enrol.
Corequisites
Pass these before, or take them in the same semester.
After PHR1101
No unit lists PHR1101 as a prerequisite in the 2025 handbook.
Overview
This unit will focus on the management of selected endocrine and renal conditions by relating the pathophysiology and clinical use of medicines and the development of a patient-specific care plan. This unit also introduces the concepts and applications of evidence-based practice, key components of medication safety and review and a systems-based approach to healthcare with respect to patients with complex needs. Pharmaceutical formulation principles and extemporaneous compounding techniques will be highlighted in this unit.
Offerings in 2025
| Teaching period | Campus | Mode |
|---|---|---|
| First semester | Parkville | Bld blk |
Assessment
- Mid semester testQuiz / Test15%
- End of semester testQuiz / Test15%
- Extemporaneous compounding laboratory examExaminationCompetency hurdle20%
- Final examinationExaminationCompetency hurdle50%
Learning outcomes
When you finish this unit, you should be able to:
- 1
Describe the signs and symptoms, diagnostic and epidemiological aspects of selected endocrine and renal conditions.
- 2
List and prioritise pharmacological and non-drug therapy options for the management of selected endocrine and renal conditions.
- 3
Evaluate a patient's endocrine or renal condition and create a complete, patient-specific care plan that applies established clinical guidelines and a comprehensive review of potential medication-related problems.
- 4
Apply counselling strategies that optimise therapy outcomes including behavioural change for patients in the management of selected renal and endocrine conditions including when referral for medical assessment is required in selected cardiovascular, endocrine and renal conditions.
- 5
Describe and apply the general principles concerning the formulation of various medicinal dosage forms including tablets and capsules, solutions, suspensions and emulsions and extemporaneously compounded products and explain the rationale for the inclusion of each of the excipients.
- 6
Define, incorporate, interpret and apply a standardised approach to patient-centred care.
- 7
Interpret, retrieve, appraise and apply evidence-based practice.
- 8
Explain the key components of medication safety and policy documents, in the context of a pharmacist and a systems-based approach to healthcare.
Workload and teaching
- Workshops27 hours
- Assessments6 hours
- Laboratories6 hours
- Applied sessions0.5 hours
- Teaching approachOnline learning
- Teaching approachActive learning
- Teaching approachRole play
- Teaching approachCase-based teaching
- Teaching approachProblem-based learning
- Teaching approachEnquiry-based learning
Workload requirements include online modules and interactive on-campus workshops and laboratories which require compulsory attendance.
- Seventy-two hours of independent study
- Twenty-four hours of pre-learning activities (2 hours per week)
- Thirty-three hours of applied sessions and laboratory workshops (3 hours per week)
Learning resources
Required resources
Australian Medicines Handbook (AMH) Online
Australian Pharmaceutical Formulary (APF)
MIMS Online
eTG Online
Contacts
- Unit Coordinators
- Dr Suzanne Caliph
- Chief Examiners
- Dr Suzanne Caliph